Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
1
self-reported band not used
Founded
2005
21 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Public Company
self-reported
Description
Sienna Cancer Diagnostics is a medical technology company that develops and commercialises diagnostic tests to assist in the early and accurate diagnosis of cancer, enabling improved treatment and patient outcomes. Sienna’s first product, hTERT, a test that aids in the diagnosis of bladder cancer, has been launched and is being commercialised through a growing network of distribution partners globally.
Sienna entered the global liquid biopsy market in 2019 via the strategic acquisition of a “Molecular Net” technology called SIEN-NET. The first commercial embodiment of SIEN-NET is EXO-NET, which has been specifically designed to purify a patient sample for cancer-associated exosomes.
The Company recently announced the signing of an exclusive worldwide licence agreement with the University of Adelaide to develop and commercialise a unique cancer probe, SubB2M, which binds to a unique sugar molecule only present in human cancers and can detect its presence in the serum of cancer patients. SubB2M has the potential to detect cancer in a range of testing modalities such as liquid biopsies, immunoassays, circulating tumor cell assays and PET imaging.
Specialties
All 5 specialties
- Development and commercialisation of novel diagnostic tests
- Global clinical networks & partnerships
- CE Marked / IVD Registered Product
- Medical technology / Medical Devices
- Pathology Diagnostics (IVD Devices)
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU23 Normanby Rd; Notting Hill, Victoria 3168Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
How many people work at this brand?
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Sienna Cancer Diagnostics - A BARD1 Life Sciences company have offices?
One address on record, Australia only. Primary: 23 Normanby Rd, Notting Hill, Victoria 3168.
Has Sienna Cancer Diagnostics - A BARD1 Life Sciences company raised funding?
None linked to this brand.
What does this brand list as its specialties?
Five tags on the brand's own list, among them Development and commercialisation of novel diagnostic tests, Global clinical networks & partnerships and CE Marked / IVD Registered Product.
Which companies are listed alongside this brand?
Four peer profiles on record: Incisive Technologies and INOVIQ Ltd (ASX:IIQ).